Assenagon Asset Management S.A. Dr Reddys Laboratories LTD Transaction History

Assenagon Asset Management S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$68.26 - $76.19 $6.84 Million - $7.63 Million	-100,204 Reduced 62.53%	60,048 $4.58 Million
Q1 2024 Apr 24, 2024	SELL	$67.36 - $77.59 $2.42 Million - $2.79 Million	-35,894 Reduced 18.3%	160,252 $11.8 Million
Q4 2023 Jan 17, 2024	BUY	$64.27 - $69.9 $10.2 Million - $11.1 Million	158,141 Added 416.11%	196,146 $13.6 Million
Q3 2023 Nov 06, 2023	SELL	$61.9 - $72.77 $7.96 Million - $9.36 Million	-128,662 Reduced 77.2%	38,005 $2.54 Million
Q2 2023 Jul 25, 2023	SELL	$53.34 - $63.11 $4.37 Million - $5.17 Million	-81,949 Reduced 32.96%	166,667 $10.5 Million
Q1 2023 Apr 18, 2023	BUY	$51.63 - $56.93 $2.71 Million - $2.99 Million	52,578 Added 26.82%	248,616 $14.2 Million
Q4 2022 Jan 12, 2023	BUY	$51.15 - $57.45 $6.8 Million - $7.64 Million	132,917 Added 210.57%	196,038 $10.1 Million
Q3 2022 Oct 27, 2022	BUY	$49.9 - $57.32 $3.15 Million - $3.62 Million	63,121 New	63,121 $3.3 Million

245

23.1M

12.7K

6.1K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.55B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.